Search

everythinglearnresearchcommunity

for

Search:↓

Teledermatology became a valuable and convenient tool for skin care during the COVID-19 pandemic.

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

COVID-19 vaccines can trigger autoimmune flares but are still beneficial for patients with autoimmune conditions.

A patient developed a severe skin reaction and died after taking hydroxychloroquine for COVID-19.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

COVID-19 can cause various skin issues, like rashes and lesions, which are more common in younger patients and can be linked to more severe complications.

Public interest in skin issues changed during COVID-19, with more focus on dry skin, hair problems, and hand eczema.

Some drugs may help treat both COVID-19 and radiation injury.

Your lifestyle and health can affect your chances of getting COVID-19; not enough sleep, lots of exercise, and hair loss can increase risk, while washing hands, eating fruit daily, and taking vitamins A and C can lower it.

Some nutraceuticals may help in COVID-19 prevention and treatment, but more research is needed.

Some recovered COVID-19 patients experience skin, hair, and nail issues, suggesting they need follow-up care.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

Patients with long COVID after Omicron had fewer hospitalizations and milder symptoms but more fatigue, insomnia, and cough compared to those with Delta.

COVID-19 can cause skin problems in children.

COVID-19 can cause hair loss starting as early as 18 days after infection.

COVID-19 can cause temporary hair loss, often starting around 7-8 weeks after recovery, with factors like Vitamin D deficiency, other diseases, medication, and stress potentially contributing.

Hair loss (telogen effluvium) cases rose during the pandemic, especially in Hispanic and non-White groups, and were linked to other health issues and COVID-19.

The treatment might help COVID-19 related hair loss, but more research is needed.

Older, obese people with many COVID-19 symptoms are more likely to suffer from severe long-term COVID-19 effects.

Long COVID-19 patients with skin pain might have a nerve condition that responds to a medication called gabapentin.

COVID-19 can cause hair loss and nail changes in some patients.

An HIV patient's complete hair loss was reversed after switching from lopinavir/ritonavir to nelfinavir.

The Covishield COVID-19 vaccine caused skin-related side effects in 1.23% of the people vaccinated in the study from India.

Using mesenchymal stem cells or their exosomes is safe for COVID-19 patients and helps improve lung healing and oxygen levels.

Kampo medicine can help treat general fatigue from long COVID.

Long-lasting COVID-19 symptoms like fatigue and breathing difficulties can persist for over 60 days, requiring ongoing care.

Researchers developed a new method to test hair growth drugs and found that adult cells are best for hair growth, but the method needs improvement as it didn't create mature hair follicles.

Some people with a history of autoimmune hair loss experienced worsening symptoms after COVID-19 vaccination.

Hair shedding after COVID-19 is more linked to the disease's severity and inflammation rather than hormones, with women at higher risk.

Telemedicine is effective for diagnosing hair loss, especially in people with darker skin, during the pandemic.